BridgeBio is headquartered in Palo Alto, California.
BridgeBio disclosed revenue of 222M USD for 2024 and 9M USD for 2023.
BridgeBio has 725 employees.
BridgeBio is a life science company.
BridgeBio was founded in 2015.
3160 Porter Drive, Suite 250,
Palo Alto, California
94304
United States,
(650) 391 9740
www.bridgebio.com
BridgeBio is an Orphan disease drug platform with a robust portfolio of transformative drug programs that address rare diseases across oncology, cardiology, dermatology, neurology, and endocrinology. BridgeBio was founded in 2015 and is based in Palo Alto, California.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | 1 | - | - | - | 1 | - | 2 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
| Financial | Deals |
|---|---|
|
Goldman Sachs |
1 |
|
J.P. Morgan Securities |
1 |
| Legal | Deals |
|---|---|
|
Skadden, Arps, Slate, Meagher & Flom |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
